In the Field - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Field

Pharmaceutical Technology


INTERACT in FEBRUARY...

"Worth reading

Protein Formulation and Delivery, Second Edition (Informa Healthcare, 2007)

Eds. Eugene J. McNally and Jayne E. Hastedt




The book summarizes recent research for formulators and drug-delivery specialists. Reviewed on http://pharmtech.com/.

"Worth attending

Interphex Puerto Rico

Venue: Feb. 14–Feb. 15, San Juan, PR

More Info: http://www.interphexpuertorico.com/

Biogenerics 2008: An Open Forum on Scientific and Regulatory Issues

Venue: Mar. 2–Mar. 4, Boston, MA

More Info: http://www.barnett.neu.edu/biogenerics/

WBF 2008 North American Conference: Shaping the Future of Manufacturing

Venue: Mar.24-Mar. 27, Philadelphia, PA

More Info: http://www.wbf.org/

Interphex 2008

Venue: Mar. 26-28, Philadelphia, PA

More Info: http://www.interphex.com/




See special pullout in this issue.

To recommend books, events, or websites, email


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here